-
21
ANT1 overexpression models: Some similarities with facioscapulohumeral muscular dystrophy
Published 2022-10-01Subjects: Get full text
Article -
22
EYE PATHOLOGIES IN FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY (CASE REPORT AND LITERARY ANALYSIS)
Published 2018-10-01Subjects: Get full text
Article -
23
Surgical correction of hyperlordosis in facioscapulohumeral muscular dystrophy: A case report
Published 2017-07-01Subjects: “…Facioscapulohumeral muscular dystrophy…”
Get full text
Article -
24
Upper Limb Rehabilitation in Facioscapulohumeral Muscular Dystrophy: A Patients’ Perspective
Published 2021-12-01“…Objective: To identify (1) what exercise modalities people living with facioscapulohumeral muscular dystrophy (FSHD) are undertaking in the community as a part of their ongoing rehabilitation and (2) what future research projects would gain the support of people with FSHD. …”
Get full text
Article -
25
Early-Onset Infantile Facioscapulohumeral Muscular Dystrophy: A Timely Review
Published 2020-10-01Subjects: “…facioscapulohumeral muscular dystrophy…”
Get full text
Article -
26
Longitudinal study of MRI and functional outcome measures in facioscapulohumeral muscular dystrophy
Published 2021-03-01Subjects: Get full text
Article -
27
Optical Genome Mapping for the Molecular Diagnosis of Facioscapulohumeral Muscular Dystrophy: Advancement and Challenges
Published 2023-10-01“…Facioscapulohumeral muscular dystrophy (FSHD) is the second most common muscular dystrophy in adults, and it is associated with local D4Z4 chromatin relaxation, mostly via the contraction of the D4Z4 macrosatellite repeat array on chromosome 4q35. …”
Get full text
Article -
28
Interpretation of the Epigenetic Signature of Facioscapulohumeral Muscular Dystrophy in Light of Genotype-Phenotype Studies
Published 2020-04-01“…Facioscapulohumeral muscular dystrophy (FSHD) is characterized by incomplete penetrance and intra-familial clinical variability. …”
Get full text
Article -
29
Evaluation of Optical Genome Mapping in Clinical Genetic Testing of Facioscapulohumeral Muscular Dystrophy
Published 2023-11-01Subjects: Get full text
Article -
30
Acupuncture Improves the Facial Muscular Function in a Case of Facioscapulohumeral Muscular Dystrophy
Published 2019-04-01“…Facioscapulohumeral muscular dystrophy (FSHD) is a genetic muscle disorder in which muscles of the face, shoulder blades, and upper arms develop gradual and progressive weakness. …”
Get full text
Article -
31
Proteomics of Muscle Microdialysates Identifies Potential Circulating Biomarkers in Facioscapulohumeral Muscular Dystrophy
Published 2020-12-01Subjects: “…facioscapulohumeral muscular dystrophy…”
Get full text
Article -
32
Pathomechanisms and biomarkers in facioscapulohumeral muscular dystrophy: roles of DUX4 and PAX7
Published 2021-08-01Subjects: Get full text
Article -
33
Different molecular signatures in magnetic resonance imaging-staged facioscapulohumeral muscular dystrophy muscles.
Published 2012-01-01“…BACKGROUND: Facioscapulohumeral muscular dystrophy (FSHD) is one of the most common muscular dystrophies and is characterized by a non-conventional genetic mechanism activated by pathogenic D4Z4 repeat contractions. …”
Get full text
Article -
34
Influence of <i>DUX4</i> Expression in Facioscapulohumeral Muscular Dystrophy and Possible Treatments
Published 2023-05-01Subjects: “…facioscapulohumeral muscular dystrophy…”
Get full text
Article -
35
Correlation analysis between genotype and phenotype of patients with facioscapulohumeral muscular dystrophy type 1
Published 2019-05-01“…Objective To investigate the clinical phenotype and genotype of facioscapulohumeral muscular dystrophy type 1 (FSHD1) and the correlation between the two. …”
Get full text
Article -
36
A team approach in the diagnosis and management of facioscapulohumeral muscular dystrophy: a case report
Published 2020-09-01Subjects: “…Facioscapulohumeral muscular dystrophy…”
Get full text
Article -
37
PAX7 target genes are globally repressed in facioscapulohumeral muscular dystrophy skeletal muscle
Published 2017-12-01“…Facioscapulohumeral muscular dystrophy is a myopathy linked to ectopic expression of the DUX4 transcription factor. …”
Get full text
Article -
38
Non-myogenic mesenchymal cells contribute to muscle degeneration in facioscapulohumeral muscular dystrophy patients
Published 2022-09-01“…These cells have recently emerged as remarkable therapeutic targets for neuromuscular disorders, although to date they have been poorly investigated in facioscapulohumeral muscular dystrophy (FSHD). In this study, we characterised the non-myogenic mesenchymal stromal cell population in FSHD patients’ muscles with signs of disease activity, identified by muscle magnetic resonance imaging (MRI), and compared them with those obtained from apparently normal muscles of FSHD patients and from muscles of healthy, age-matched controls. …”
Get full text
Article -
39
A Deoxyribonucleic Acid Decoy Trapping DUX4 for the Treatment of Facioscapulohumeral Muscular Dystrophy
Published 2020-12-01Get full text
Article -
40